The Best of CAR T at the 2024 Tandem Meetings webinar was the first in a two-part CAR T webinar series. This session aired on Thursday, June 27, at 3 p.m. CDT and highlighted three talks from the 2024 Tandem Meetings of ASTCT and CIBMTR. This hour-long webinar had three fifteen-minute talks with the remaining fifteen minutes used for audience Q&A. The session is open and free to all ASTCT members and non-members. 

Presentations and Speakers:

Outpatient CAR-T in Action: Models for Staffing and Overcoming Challenges

David Porter, MD; Director, Center for Cell Therapy and Transplant, University of Pennsylvania

Role of the Microbiome in Resistance to CAR-T cell Therapies

Melody Smith, MD; Assistant Professor of Medicine, Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine

CAR T-cells and Late-Effects, Including Secondary Malignancy

Aimee Talleur, MD; Assistant Member, Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children’s Research Hospital

If you're interested in viewing/purchasing the full session recordings from the 2024 Tandem Meetings of ASTCT and CIBMTR, please click here.

Thank you to Johnson & Johnson and Legend Biotech for their generous support of this webinar series.

The New Developments in CAR T Treatments webinar is the second and final session in this two-part CAR T webinar series. This session aired on Tuesday, September 10, at 12 p.m. CDT and featured two presentations from Drs. Bachanova and Rouce on new developments in NK Cells and Point of Care Manufacturing. This hour-long webinar had two twenty-minute talks with the remaining time used for audience Q&A. The session is open and free to all ASTCT members and non-members. 

Topics and Speakers:

NK Cells

Veronika Bachanova, MD, PhD; University of Minnesota

Point of Care Manufacturing

Rayne Rouce, MD, BS; Baylor College of Medicine/Texas Children's

Thank you to Johnson & Johnson and Legend Biotech for their generous support of this webinar series.